Director of Talis Biomedical Corp (NASDAQ:TLIS), Posard Matthew L., buys 62,500 shares worth $1,000,000

According to Talis Biomedical Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 06:13 PM, company Director, Posard Matthew L. disclosed buying 62,500 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $1,000,000 in total. As of Feb 17, Posard Matthew L. now owns 62,500 shares in total worth about $1,390,625.0.

For the last few recent trades made by Talis Biomedical Corp (NASDAQ:TLIS) Director, Posard Matthew L., we have the following information:

Posted by George Daniels on Friday February 19 2021, 10:43 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0